Patrys Limited

Company

Last mentioned: Mar 17, 2026

Timeline

  1. Clinical Evaluation

    Anticipated delivery of therapeutic batches for Phase I/II clinical trials.

  2. cGMP Manufacturing

    Commencement of current Good Manufacturing Practice (cGMP) runs for clinical supply.

  3. Process Development

    Expected completion of initial process optimization and scale-up activities.

  4. Program Initiation

    BioCina officially starts the comprehensive manufacturing program for the Patry therapeutic.

Stories mentioning Patrys Limited 1

market-trends Bullish

BioCina Scales Manufacturing for Patry's Novel Delirium Therapeutic

BioCina has launched a comprehensive manufacturing program for the Patry proprietary injectable therapeutic, a novel treatment designed to alleviate delirium. This partnership marks a critical milestone in bringing a specialized solution to a high-need clinical area with limited current treatment options.

2 sources